by Lee Seonae
Published 28 Jan.2022 07:01(KST)
[Asia Economy Reporter Lee Seon-ae]
◆Cellid=Approval of IND for Phase 2b clinical trial of COVID-19 preventive vaccine AdCLD-CoV19-1
◆Jinsung TEC=Acquisition of 2,769,998 shares of Thai subsidiary, investment of 10 billion KRW
◆Areus=Change of largest shareholder from Park Rae-seong to Shin Doo-young
◆Bioneer=Approval from Ministry of Food and Drug Safety for export of COVID-19 Delta and Omicron differentiation diagnostic kits
◆LIS=Early acquisition of 4 billion KRW 24th series bearer unsecured private convertible bonds
◆Ewon Compotech=Acquisition and resale of 5 billion KRW 3rd series bearer unsecured private convertible bonds
◆Ginaine Pharm=Reviewing third-party allotment capital increase and convertible bond issuance
◆Yujin Enterprise=Investment of 8 billion KRW in related party Nanum Lotto